James A Landro
age ~63
from Cheshire, CT
- Also known as:
-
- James Anthony Landro
- Jim A Landro
- Anthony N Landro
- James A Lan
- Phone and address:
-
412 Maple Ave, Cheshire, CT 06410
2032719874
James Landro Phones & Addresses
- 412 Maple Ave, Cheshire, CT 06410 • 2032719874
- Wakefield, MA
- 99 Bartlett St, Charlestown, MA 02129
- 1254 Taft Ave, Merrick, NY 11566 • 5162216737
- North Merrick, NY
- College Park, MD
- Chicago, IL
- 412 Maple Ave, Cheshire, CT 06410 • 2032319949
Education
-
Degree:Graduate or professional degree
Name / Title
Company / Classification
Phones & Addresses
Manager
VASCUMAB, LLC
C/O Wiggin And Dana Llp, New Haven, CT 06510
412 Maple Ave, Cheshire, CT 06410
23 Business Park Dr, Branford, CT 06405
412 Maple Ave, Cheshire, CT 06410
23 Business Park Dr, Branford, CT 06405
Us Patents
-
Methods For Screening And Identifying Compounds
view source -
US Patent:20050064531, Mar 24, 2005
-
Filed:Aug 4, 2004
-
Appl. No.:10/911242
-
Inventors:James Landro - Cheshire CT, US
David Osterman - Glastonbury CT, US
Walter Pickett - Madison CT, US -
Assignee:Bayer Pharmaceuticals Corporation - West Haven CT
-
International Classification:C12Q001/48
-
US Classification:435015000
-
Abstract:The present invention relates to methods for assessing enzyme activity utilizing a phase partition system. In addition, the present invention also relates to methods for screening and identifying compounds that may be used, for example, for the treatment of diabetes, diabetes-related disorders, obesity, cardiovascular disease, cancer, and other diseases or disorders, using this phase partition system.
-
Methods For Screening And Identifying Compounds
view source -
US Patent:20060068456, Mar 30, 2006
-
Filed:Nov 2, 2005
-
Appl. No.:11/266030
-
Inventors:James Landro - Cheshire CT, US
David Osterman - Glastonbury CT, US
Walter Pickett - Madison CT, US -
Assignee:Bayer Pharmaceuticals Corporation - West Haven CT
-
International Classification:C12Q 1/48
-
US Classification:435015000
-
Abstract:The present invention relates to methods for assessing enzyme activity utilizing a phase partition system. In addition, the present invention also relates to methods for screening and identifying compounds that may be used, for example, for the treatment of diabetes, diabetes-related disorders, obesity, cardiovascular disease, cancer, and other diseases or disorders, using this phase partition system.
-
Anti-Apoc3 Antibodies And Methods Of Use Thereof
view source -
US Patent:20190241648, Aug 8, 2019
-
Filed:Jan 7, 2019
-
Appl. No.:16/241407
-
Inventors:- Nijmegen, NL
Hans de Haard - Oudelande, NL
James A. Landro - Cheshire CT, US -
International Classification:C07K 16/18
A61P 3/06
A61P 9/10
A61K 31/397 -
Abstract:The instant disclosure provides antibodies that specifically bind to ApoC3 (e.g., human ApoC3) and antagonize ApoC3 function. Also provided are pharmaceutical compositions comprising these antibodies, nucleic acids encoding these antibodies, expression vectors and host cells for making these antibodies, and methods of treating a subject using these antibodies.
Classmates
Bunnell High School, Stra...
view sourceGraduates:
James Landro (1984-1986),
John Manfredi (1974-1978),
Cheryl Fraser (1968-1972)
John Manfredi (1974-1978),
Cheryl Fraser (1968-1972)
Youtube
Get Report for James A Landro from Cheshire, CT, age ~63